Rojas S, Rey Chaves CE, Robledo S, Conde D, Sabogal Olarte JC. Primary hepatic angiosarcoma: a systematic review. Ann Med Surg (Lond). 2024;86(3):1601–5. https://doi.org/10.1097/ms9.0000000000001584.

Article  PubMed  Google Scholar 

Chaudhary P, Bhadana U, Singh RA, Ahuja A. Primary hepatic angiosarcoma. Eur J Surg Oncol. 2015;41(9):1137–43. https://doi.org/10.1016/j.ejso.2015.04.022.

Article  CAS  PubMed  Google Scholar 

Durmaz S, Basak M, Ozguven BY, Eken KG, Erturk SM. Primary hepatic angiosarcoma: a rare and very aggressive liver tumour. J Coll Physicians Surg Pak. 2022;32(12):Ss209-ss211. https://doi.org/10.29271/jcpsp.2022.Supp.S209.

Article  PubMed  Google Scholar 

Weitz J, Klimstra DS, Cymes K, et al. Management of primary liver sarcomas. Cancer. 2007;109(7):1391–6. https://doi.org/10.1002/cncr.22530.

Article  PubMed  Google Scholar 

Zocchetti C. Liver angiosarcoma in humans: epidemiologic considerations. La Medicina del Lavoro. 2001;92(1):39–53.

CAS  PubMed  Google Scholar 

Maluf D, Cotterell A, Clark B, Stravitz T, Kauffman HM, Fisher RA. Hepatic angiosarcoma and liver transplantation: case report and literature review. Transplantation Proc. 2005;37(5):2195–9. https://doi.org/10.1016/j.transproceed.2005.03.060.

Article  CAS  Google Scholar 

Pickhardt PJ, Kitchin D, Lubner MG, Ganeshan DM, Bhalla S, Covey AM. Primary hepatic angiosarcoma: multi-institutional comprehensive cancer centre review of multiphasic CT and MR imaging in 35 patients. Eur Radiol. 2015;25(2):315–22. https://doi.org/10.1007/s00330-014-3442-0.

Article  PubMed  Google Scholar 

Zheng YW, Zhang XW, Zhang JL, et al. Primary hepatic angiosarcoma and potential treatment options. J Gastroenterol Hepatol. 2014;29(5):906–11. https://doi.org/10.1111/jgh.12506.

Article  CAS  PubMed  Google Scholar 

Mangla A, Cioffi G, Barnholtz-Sloan JS, Lee RT. Treatment outcomes for primary hepatic angiosarcoma: National Cancer Database Analysis 2004–2014. Curr Oncol. 2022;29(5):3637–46. https://doi.org/10.3390/curroncol29050292.

Article  PubMed  PubMed Central  Google Scholar 

Wilson GC, Lluis N, Nalesnik MA, et al. Hepatic angiosarcoma: a multi-institutional, international experience with 44 cases. Ann Surg Oncol. 2019;26(2):576–82. https://doi.org/10.1245/s10434-018-7062-9.

Article  PubMed  Google Scholar 

Bioulac-Sage P, Laumonier H, Laurent C, Blanc JF, Balabaud C. Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis. 2008;28(3):302–14. https://doi.org/10.1055/s-0028-1085098.

Article  PubMed  Google Scholar 

Zeng D, Cheng J, Gong Z, Chen J, Long H, Zhu B. A pooled analysis of primary hepatic angiosarcoma. Jpn J Clin Oncol. 2020;50(5):556–67. https://doi.org/10.1093/jjco/hyaa017.

Article  PubMed  Google Scholar 

Biswas A, Harbin S, Irvin E, Johnston H, Begum M, Tiong M, Apedaile D, Koehoorn M, Smith P. Sex and gender differences in occupational hazard exposures: a scoping review of the recent literature. Curr Environ Health Rep. 2021;8(4):267–80. https://doi.org/10.1007/s40572-021-00330-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zaiser C, Laskowski NM, Müller R, Abdulla K, Sabel L, Ballero C, Brandt G, Paslakis G. The relationship between anabolic androgenic steroid use and body image, eating behavior, and physical activity by gender: a systematic review. Neurosci Biobehavioral Rev. 2024;163:105772. https://doi.org/10.1016/j.neubiorev.2024.105772.

Article  CAS  Google Scholar 

U.S. Census Bureau, “QuickFacts,” <https://www.census.gov/quickfacts/>, accessed on October 23, 2024

Naka N, Ohsawa M, Tomita Y, et al. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol. 1996;61(3):170–6. https://doi.org/10.1002/(sici)1096-9098(199603)61:3%3c170::Aid-jso2%3e3.0.Co;2-8.

Article  CAS  PubMed  Google Scholar 

Buehler D, Rice SR, Moody JS, et al. Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience. Am J Clin Oncol. 2014;37(5):473–9. https://doi.org/10.1097/COC.0b013e31827e4e7b.

Article  PubMed  PubMed Central  Google Scholar 

Li DB, Si XY, Wan T, Zhou YM. A pooled analysis of treatment and prognosis of hepatic angiosarcoma in adults. Hepatobiliary Pancreat Dis Int. 2018;17(3):198–203. https://doi.org/10.1016/j.hbpd.2018.04.005.

Article  CAS  PubMed  Google Scholar 

Ramakrishnan N, Mokhtari R, Charville GW, Bui N, Ganjoo K. Management strategies and outcomes in primary liver angiosarcoma. Am J Clin Oncol. 2023;46(10):439–44. https://doi.org/10.1097/coc.0000000000001032.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. The Lancet 1997;350(9092):1647–1654. https://doi.org/10.1016/S0140-6736(97)08165-8

Huang NC, Kuo YC, Chiang JC, et al. Hepatic angiosarcoma may have fair survival nowadays. Medicine (Baltimore). 2015;94(19):e816. https://doi.org/10.1097/md.0000000000000816.

Article  CAS  PubMed  Google Scholar 

Young RJ, Natukunda A, Litière S, Woll PJ, Wardelmann E, van der Graaf WT. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials. Eur J Cancer. 2014;50(18):3178–86. https://doi.org/10.1016/j.ejca.2014.10.004.

Article  CAS  PubMed  Google Scholar 

Watson S, Verret B, Ropert S, Adam J, Bahleda R, Briand S, Cavalcanti A, Chamseddine AN, Court C, Fadel E, Faron M, Haddag-Miliani L, Henon C, Pechoux CL, Levy A, Mercier O, Ngo C, Honoré C, Cesne AL, Mir O. Single-agent gemcitabine in patients with advanced, pre-treated angiosarcoma: a multicenter, retrospective study. Cancer Med. 2023;12(3):3160–6. https://doi.org/10.1002/cam4.5147.

Article  CAS  PubMed  Google Scholar 

Italiano A, Cioffi A, Penel N, Levra MG, Delcambre C, Kalbacher E, Chevreau C, Bertucci F, Isambert N, Blay JY, Bui B, Antonescu C, D’Adamo DR, Maki RG, Keohan ML. Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas. Cancer. 2012;118(13):3330–6. https://doi.org/10.1002/cncr.26599.

Article  CAS  PubMed  Google Scholar 

Wagner MJ, Othus M, Patel SP, Ryan C, Sangal A, Powers B, Budd GT, Victor AI, Hsueh CT, Chugh R, Nair S, Leu KM, Agulnik M, Sharon E, Mayerson E, Plets M, Blanke C, Streicher H, Chae YK, Kurzrock R. Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). J Immunother Cancer. 2021;9(8):e002990. https://doi.org/10.1136/jitc-2021-002990.

Article  PubMed  PubMed Central  Google Scholar 

Agulnik M, Yarber JL, Okuno SH, von Mehren M, Jovanovic BD, Brockstein BE, Evens AM, Benjamin RS. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013;24(1):257–63. https://doi.org/10.1093/annonc/mds237.

Article  CAS  PubMed  Google Scholar 

Agulnik M, Schulte B, Robinson S, Hirbe AC, Kozak K, Chawla SP, Attia S, Rademaker A, Zhang H, Abbinanti S, Cehic R, Monga V, Milhem M, Okuno S, Van Tine BA. An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma. Eur J Cancer. 2021;154:201–8. https://doi.org/10.1016/j.ejca.2021.06.027.

Article  CAS  PubMed  Google Scholar 

Locker GY, Doroshow JH, Zwelling LA, Chabner BA. The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltimore). 1979;58(1):48–64. https://doi.org/10.1097/00005792-197901000-00003.

Article  CAS  PubMed  Google Scholar 

Kuba MG, Dermawan JK, Xu B, et al. Histopathologic grading is of prognostic significance in primary angiosarcoma of breast: proposal of a simplified 2-tier grading system. Am J Surg Pathol. 2023;47(3):307–17. https://doi.org/10.1097/pas.0000000000001998.

Article  PubMed  Google Scholar